The Peter Attia Drive

By: Peter Attia MD
  • Summary

  • The Peter Attia Drive will feature guests and experts that will offer advice and insight to help you optimize performance, health, longevity, critical thinking, and life. It’s hosted by Stanford M.D., TED speaker, and longevity expert Dr. Peter Attia, founder of Attia Medical, PC, a medical practice with offices in San Diego and New York City.
    Copyright © Peter Attia, MD
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • #321 – Dopamine and addiction: navigating pleasure, pain, and the path to recovery | Anna Lembke, M.D.
    Oct 14 2024

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Anna Lembke is the Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic and author of Dopamine Nation: Finding Balance in the Age of Indulgence. In this episode, Anna dives deep into the biochemistry and neurobiology of addiction, exploring the critical role of dopamine and the prefrontal cortex. She shares her framework for diagnosing and treating addiction, providing real-world examples involving alcohol, gambling, cannabis, social media, and more. Anna outlines the risk factors for addiction, including inherited and nurture-based risks, explores the rise of addictions in younger generations, and discusses effective ways to address these issues with children. Additionally, she touches on healthy coping strategies, the evolution of the “marshmallow experiment,” and provides insights into GLP-1 agonists as a possible tool for addiction treatment. Finally, she reflects on the value of 12-step programs and how she navigates the emotional challenges of her work.

    We discuss:

    • The role of dopamine and the prefrontal cortex in addiction [3:00];
    • The clinical definition of addiction and the behavioral criteria for diagnosing it [13:00];
    • Assessing alcohol use: patterns, risks, and addiction diagnosis [17:15];
    • Applying the addiction diagnosis framework using gambling as an example [21:45];
    • Exploring addiction variability: how nature, nurture, and access shape individual vulnerability and drug of choice [25:15];
    • How abstinence from addictive behaviors can help reset the brain’s reward system and improve mental health [41:15];
    • Safely abstaining from addiction substances, drugs needing medical supervision, and other key considerations [51:30];
    • Transitioning from abstinence to long-term recovery: tools and considerations [59:00];
    • Exploring behavioral addictions like sex addiction, and the gender differences in addiction patterns [1:08:30];
    • Factors contributing to the increasing levels of addiction across the world [1:13:45];
    • How online pornography can affect young boys' developing brains and lead to addictive behaviors, and strategies for parents to address this issue [1:23:30];
    • The link between social media use and declines in mental health, potential solutions, and protective measures [1:34:45];
    • How exercise affects brain chemistry, the role of dopamine and endorphins, and how exercise can become addictive [1:44:00];
    • Cold-water immersion for mood regulation, and other healthy coping strategies [1:47:15];
    • The “marshmallow experiment”: how broken promises affect behavior and trustworthy environments help children develop self-control [1:54:00];
    • Can GLP-1 agonists be useful in treating addiction? [1:58:30];
    • The benefits of 12-step programs [2:06:00];
    • Why understanding a patient’s story is essential for meaningful psychiatric care [2:11:45]; and
    • More.

    Connect With Peter on Twitter, Instagram, Facebook and YouTube

    Show more Show less
    2 hrs and 22 mins
  • #320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape
    Oct 7 2024
    View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter In this “Ask Me Anything” (AMA) episode, Peter dives back into the increasingly popular topic of GLP-1 agonists, such as Ozempic and Mounjaro, which have garnered widespread attention for their ability to promote weight loss. Peter covers the latest findings in this rapidly evolving landscape, including new insights into their long-term efficacy, side effects, and what happens when the drug is discontinued. Peter also explores their impact on body composition and how resistance training interacts with these treatments. Additionally, he compares different GLP-1 receptor agonists and discusses promising new drugs in the pipeline. Finally, Peter addresses questions about the role of compounding pharmacies in the GLP-1 agonist market, compares oral vs. injectable options, and provides key considerations for anyone deciding whether to use a GLP-1 agonist for weight loss. If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #64 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here. We discuss: The rapidly evolving landscape of GLP-1 agonists [2:15];The mechanism of GLP-1 agonists, their origin as diabetes treatments, and how they evolved into weight-loss drugs [6:45];Overview of new data and open questions related to the benefits and risks of GLP-1 agonists [10:30];New insights into the long-term safety of GLP-1 agonists, side effects, and more [16:45];The long-term efficacy of GLP-1 agonists, financial barriers, and more [19:45];The mechanisms behind GLP-1 agonists' ability to promote weight loss [22:00];New data on body weight changes after discontinuing the drug [26:00];Effects of GLP-1 agonists on lean mass and body composition, and the role of protein and resistance training in preserving muscle [31:30];Semaglutide vs. tirzepatide: comparing benefits and side effects [36:30];How compounding pharmacies affect availability of GLP-1 drugs and the types of formulations that are available [39:15];How do oral formulations of GLP-1 drugs compare to injectable formulations? [44:15];How do sublingual (under tongue) formulations of GLP-1 drugs compare to injectable formulations? [46:15];Guidance for using compounding pharmacies to purchase GLP-1 agonists [47:15];Data on retatrutide—a promising new triple receptor agonist in the pipeline [50:15];Can GLP-1 agonists be beneficial for sleep apnea and immune function? [57:00];Potential neuroprotective benefits of GLP-1 agonists: impact on dementia risk [1:00:45];Exploring why GLP-1 agonists may reduce the risk of cancer, kidney disease, and cardiovascular disease [1:04:00];How GLP-1 agonists might boost fertility in women [1:10:15];Early indications that GLP-1 agonists may help treat substance abuse disorders [1:12:00];Potential health risks of GLP-1 agonists: addressing thyroid cancer concerns and the unknowns due to lack of data [1:14:00];Examining the potential link between GLP-1 agonists and increased depression or suicidal ideation [1:16:00];Major remaining questions: the effects of cyclic use, rebound appetite, impact on adolescents' development, and more [1:19:30];Key considerations when deciding whether to use a GLP-1 agonist for weight loss [1:23:45]; andMore. Connect With Peter on Twitter, Instagram, Facebook and YouTube
    Show more Show less
    21 mins
  • #319 ‒ Peter's key takeaways on liver health, heart rate variability, AI in medicine, klotho, and lactate metabolism | Quarterly Podcast Summary #2
    Sep 30 2024

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this quarterly podcast summary (QPS) episode, Peter summarizes his biggest takeaways from the last three months of guest interviews on the podcast. Peter shares key insights from each episode, covering diverse topics such as liver health with Julia Wattacheril, heart rate variability with Joel Jamieson, artificial intelligence with Zak Kohane, klotho for brain health with Dena Dubal, and lactate and lactate metabolism with George Brooks. Additionally, Peter shares any personal behavioral adjustments or modifications to his patient care practices that have arisen from these engaging discussions.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the episode #319 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • Overview of topics, and the positive feedback on the quarterly podcast summary format [2:00];
    • Julia Wattacheril episode: liver health and disease [4:00];
    • Noninvasive methods to diagnose liver conditions, and how to manage and improve liver health [16:00];
    • Joel Jamieson episode: heart rate variability (HRV) for training and health [27:15];
    • Practical tools for measuring HRV and how it informs training and recovery decisions [37:00];
    • Zak Kohane episode: artificial intelligence and medicine [47:15];
    • The current role of AI in medicine and how it could revolutionize medicine in the future [53:45];
    • The limitations and concerns pertaining to AI [1:00:15];
    • Dena Dubal episode: the potential benefits of klotho for brain health [1:05:00];
    • Animal studies on klotho and brain health [1:11:00];
    • Genetics-based variations in klotho levels in humans and their impact on cognition, disease risk, and longevity [1:14:15];
    • Testing klotho levels, the significance of the KL-VS variant, the role of exercise in increasing klotho, and more [1:17:30];
    • The potential of klotho as a treatment for cognitive decline and Alzheimer's disease [1:23:15];
    • George Brooks episode: a new paradigm to think about lactate and lactate metabolism [1:27:45];
    • The potential for lactate infusions to aid in brain recovery following a head injury [1:34:00];
    • The relationship between lactate and cancer, and the impact of exercise on lactate levels and cancer risk [1:36:30]; and
    • More.

    Connect With Peter on Twitter, Instagram, Facebook and YouTube

    Show more Show less
    28 mins

What listeners say about The Peter Attia Drive

Average customer ratings
Overall
  • 5 out of 5 stars
  • 5 Stars
    24
  • 4 Stars
    1
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Performance
  • 5 out of 5 stars
  • 5 Stars
    23
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Story
  • 5 out of 5 stars
  • 5 Stars
    23
  • 4 Stars
    1
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0

Reviews - Please select the tabs below to change the source of reviews.

Sort by:
Filter by:
  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Love!

As usual learned a lot.
Can't wait for the next episode.
Three more words.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

1 person found this helpful

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

so grateful..

Remarkable podcast with so much valuable information on how to live our best life.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

1 person found this helpful

  • Overall
    5 out of 5 stars
  • Story
    5 out of 5 stars

Helpful

Reminded me of the importance of exercise. Thank you for this experience. Very helpful and insightful.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Very informative

I get so much out of Peter Attia. Thanks so much for doing all this.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Deep info

Top of the line pro information. Complex but understandabele, and very complete, superb guests, great interviews

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Responsibly sourced information.

Excellently sourced and presented information that allows the listener to discern what to take away and what to leave. Great guests and peter is a great interviewer.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

excellent knowledge!

as a female trainer of over 20 years I thoroughly appreciate listening to thoughtful dedicated and committed women in the industry. excellent interview I learned a lot thank you so much.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

1 person found this helpful

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

A Smart Guy Talks to Other Smart People

If you are a person concerned about health and longevity and are ready to dive into more technical, sciencey info this dude is for you. Recommend you have some level of understanding of biology to reap most benefits of listening.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

WOW!

Great information on concussions & their treatment. amazing how far the knowledge base has increased in 20 years.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!